consumers who use both Dexcom glucose biosensors, including its over-the-counter product Stelo, and the Oura Ring can track ...

Waiting on Apple to add glucose tracking on a smartwatch to learn about your blood sugar? Don't. Try a biosensor instead.

CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...

Every study in these AID systems has been done with the DexCom sensor. So there aren't any head-to-head studies. They've all been run with DexCom, at least with our pump partners, and that's the ...

DexCom concluded the third quarter of 2024 on a positive note, with earnings and revenues surpassing expectations. Key drivers included significant contributions from the Sensor segment and robust ...

This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

DexCom, Inc. DXCM is scheduled to release third ... Potential robust contributions from the Sensor segment, and domestic and international revenue growth are likely to have been the key catalysts ...

DexCom, Inc. DXCM reported third-quarter 2024 ... The broader S&P 500 index has moved up 21.6% in the same period. Sensor and other revenues (96% of total revenues) increased 9% on a year-over ...